Global Health Ltd
ASX:GLH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (25.5), the stock would be worth AU$-0.3 (535% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -5.9 | AU$0.07 |
0%
|
| Industry Average | 25.5 | AU$-0.3 |
-535%
|
| Country Average | 16.5 | AU$-0.19 |
-382%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Global Health Ltd
ASX:GLH
|
4m AUD | -5.9 | -4.9 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 21.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.6B USD | 19.1 | 28.1 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.8B AUD | 76.4 | 61.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 9.8 | 20.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
52.1B SEK | -134.4 | 97 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD | 15 | 41.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.3B USD | 14.1 | 17.9 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.7B USD | 0 | 0 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.3B CNY | -122.4 | -62.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 267.9 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 16.5 |
| 70th Percentile | 24.5 |
| Max | 6 797.5 |
Other Multiples
Global Health Ltd
Glance View
Global Health Ltd. engages in the provision of e-health solutions to the healthcare industry supporting healthcare delivery in hospitals and community settings. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-04-04. The firm is also engaged in the development of systems integration software that enables data to be securely exchanged between multiple, disparate applications within an enterprise and across the healthcare value chain. The Company’s software targets organizations that provide healthcare services to people living with chronic conditions such as Mental Health illness, Diabetes, and Cardiovascular disease. Its solutions include electronic medical records, patient administration systems, practice management systems, clinical records, secure connectivity, patient engagement platforms, and consumer health records. The firm serves various sectors, such as aged and home care, allied health, community health, general practice, mental health, pharmacy, specialist health, and hospitals.